1. Home
  2. MFP vs TRVI Comparison

MFP vs TRVI Comparison

Compare MFP & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Midera Food Processing Inc. Common Stock

MFP

Midera Food Processing Inc. Common Stock

N/A

Current Price

$44.85

Market Cap

1.8B

Sector

Industrials

ML Signal

N/A

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

N/A

Current Price

$15.23

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MFP
TRVI
Founded
2025
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
MFP
TRVI
Price
$44.85
$15.23
Analyst Decision
Buy
Strong Buy
Analyst Count
5
11
Target Price
★ $46.67
$28.18
AVG Volume (30 Days)
409.1K
★ 1.8M
Earning Date
11-17-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 31.91
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.60
N/A
Revenue Next Year
$6.07
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.51
$9.82
52 Week High
$52.58
$20.22

Technical Indicators

Market Signals
Indicator
MFP
TRVI
Relative Strength Index (RSI) 60.86 62.87
Support Level $39.58 $13.08
Resistance Level $46.15 $15.96
Average True Range (ATR) 2.04 0.72
MACD 0.36 0.29
Stochastic Oscillator 97.62 98.80

Price Performance

Historical Comparison
MFP
TRVI

About MFP Midera Food Processing Inc. Common Stock

Midera Food Processing Inc provides food processing equipment and automation solutions for industrial protein, bakery, and snack producers, delivering total line solutions from preparation and thermal processing through packaging. The company operates through a portfolio of brands and serves food processors globally. It serves various international food processing companies and producers of protein products, such as bacon, charcuterie, sausage and hot dogs, egg bites, poultry, alternative protein, lunch meat and pet food, and producers of bakery products, such as bread and buns, artisan bread, cakes and muffins, etc. The company generates revenue from the design, manufacturing and installation of food processing equipment and technology solutions and aftermarket parts and service.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: